Orchid Pharma

Orchid Pharma Ltd Key Ratios

NSEBSE

₹728.35

(1.42%)

Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Orchid Pharma Ltd

FINANCIALS

Profit & Loss Balance Sheet Cash Flow Ratios Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Growth matrix (%)
Revenue growth	24.32	-11.41	-25.61	-14.25
Op profit growth	6.71	-295.42	-262.34	-308.68
EBIT growth	-43.32	-65.39	30.41	-19.74
Net profit growth	-98.32	-11.09	-62.84	-28.79
Profitability ratios (%)
OPM	9.49	11.06	-5.01	2.29
EBIT margin	-4.44	-9.75	-24.98	-14.24
Net profit margin	-0.34	-25.89	-25.79	-51.65
RoCE	-2.2	-3.14	-6.28	-3.74
RoNW	-0.07	-4.1	254.3	14.01
RoA	-0.04	-2.08	-1.62	-3.39
Per share ratios (₹)
EPS	0.39	-28.55	-32.11	0
Dividend per share	0	0	0	0
Cash EPS	-21.79	-55.23	-62.96	-54.63
Book value per share	158.6	159.96	187.66	-88.99
Valuation ratios
P/E	728.97	-86.34		0
P/CEPS	-13.04	-44.63		-0.2
P/B	1.79	15.41		-0.12
EV/EBIDTA	22.85	161.44		83.19
Payout (%)
Dividend payout	0	0	0	0
Tax payout	0	0	0	-11.57
Liquidity ratios
Debtor days	99.89	82.58	67.34	75.93
Inventory days	106.17	119.45	120.49	108.21
Creditor days	-100.04	-96.45	-157.48	-216.58
Leverage ratios
Interest coverage	0.77	0.85	30.51	0.32
Net debt / equity	0.4	0.66	0.51	-3.65
Net debt / op. profit	4.89	8.69	-15.39	184.54
Cost breakup (₹)
Material costs	-56.03	-50.77	-47.88	-51.27
Employee costs	-11.3	-14.91	-16.68	-12.62
Other costs	-23.15	-23.25	-40.44	-33.8

Orchid Pharma : related Articles

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal

20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.